Current Nanomedicine

Dr Dipak Kumar Sarker is currently a Principal Lecturer of Physical & Chemical Sciences at the University of Brighton. He received Doctorate (PhD) in Chemical Physics from the University of East Anglia in 1995, Masters’ (MSc) in Engineering in 1992, and a Postgraduate Degree (PGDip) in Chemical Engineering in 1989. Due to his outstanding contribution, he received several awards and has published many articles in well-reputed journals.

Javed Ahmad, Ph.D., is an Assistant professor at Department of Pharmaceutics, College of Pharmacy, Najran University, Kingdom of Saudi Arabia (KSA). He received his Doctorate degree in pharmaceutical sciences from School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi (India). He is a recipient of several awards, including International Travel Award/Grant and CSIR-Senior Research Fellowship from Department of Science & Technology, Govt. of India. He has published various high quality research and review articles in peer-reviewed journals of international repute. He is reviewer of many peer-reviewed journals of Pharmaceutical Sciences. His current research interest lies in nanotechnology-mediated drug delivery and development of lipid-based nanomedicine.

Ala-Eddin Al Moustafa has earned his B.Sc. from Aleppo University and his Master as well as PhD in Developmental Biology from the Institute of Embryology of the CNRS and Collège de France, and Paris XIII University. He completed his training as a postdoctoral fellow at McGill University. Dr. Al Moustafa established the first Cancer Research Centre in Aleppo-Syria and founded the Middle-Eastern Association for Cancer Research. He published more than eighty papers, in international journals, and book chapters. His main research focuses on the roles of several Oncogenes, gene cooperation and Onco-viruses, especially high-risk HPV and EBV in human carcinogenesis and metastasis. Dr. Al Moustafa joined the College of Medicine of Qatar University, as a Professor/Principal Investigator, where he established his cancer biology lab.

Anthony Amaechi Attama, a Professor of Pharmaceutics is the Dean, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka and the Coordinator of the Drug Delivery and Nanomedicines Research Group of the University. He obtained his Ph.D in 2002 at the University of Nigeria. He was also a Visiting Researcher at Technische Universität Braunschweig in 2012 and a Visiting Professor at the Institute for Medical Research Israel-Canada (IMRIC), Hebrew University of Jerusalem in 2018. He has won many research grants and awards. He has published many research articles in peer-reviewed high impact journals.

Dr. R. Jayachandra Babu’s research area is primarily focused on formulation design and development of topical and transdermal dosage forms. Current research projects include the development of transdermal and nanoparticle dosage forms for treating infections and inflammatory disorders. His research is also focused on solubility improvement of insoluble drugs, solid state characterization of drugs and nanoparticles. His experience also includes work on the formulation development of solid dosage forms (tablets, rapid dissolve strips), liquid oral (solution and suspension) and sterile injection (solution) dosage forms. He has published over 70 peer reviewed papers and 80 research abstracts to his credit.

Maria J. Blanco-Prieto received her Pharmacy Degree from the University of Santiago de Compostela (Spain), followed by a PhD in Pharmaceutical Sciences from the University of Paris-Sud (France). She completed a post-doctoral training at the Swiss Federal Institute of Technology (ETH), Zürich, (Switzerland) and then joined the University of Navarra where presently she is Full Professor of Pharmacy and Pharmaceutical Technology. She is the author or co-author of more than 110 research papers and book chapters, 2 editorials, 5 patents and over 150 communications at scientific conferences. She has been responsible of more than 25 competitive research projects. Her research in drug delivery has won her numerous awards. She is member of several international advisory boards and societies, editorial board member of several journals such as International Journal of Pharmaceutics, Cancer Letters, Journal of Biomedical Nanotechnology.

Maria Luisa Bondì is a researcher of Pharmaceutical Technology at the Istituto per lo Studio dei Materiali Nanostrutturati- Italian National Council Research of Palermo. She is member of the Associate Professor Researchers and Pharmaceutical Technologists (Adritelf). She has 20 years of experience in the research and development of innovative formulations for the controlled release and targeting of drugs and genic material through lipid and polymeric nanoparticles for several application (e.g. medicine, food, ec.). In particular Dr. Bondì actively works in the field of brain, liver and ocular drug delivery. She has authred about 60 papers , 2 patents and edited a book and several book chapters on nanomaterials for application in therapy.

Christian Celia, Graduated in Pharmacy in 2004 at the University of Catanzaro “Magna Græcia”. In 2008, graduated as Pharm.D., and residence in Hospital Pharmacy at the University of Catanzaro “Magna Græcia”. In 2012, Prof. Celia received his Ph.D. in Pharmaceutical Science. From 2012 to 2017 Assistant Professor in Pharmaceutical Technology at the University of Chieti and Affiliated Scientist at Department of Nanomedicine, Houston Methodist Research Institute. Co-author of 61 papers, 1 proceeding paper edited in international peer-reviewed journals, and 2 Guest Editorial in international peer-reviewed journal, 100 Abstract conferences and communications, 2 book chapters, 1 Italian patent, 1 Poster Prize.

Dr. Costas Demetzos is Professor of pharmaceutical nanotechnology in the National and Kapodistrian University of Athens. He also serves as Director of the Laboratory of Pharmaceutical Technology, as President of the Hellenic Pharmaceutical Society and is an elected Member of EUFEPS’ ExCo. His research interest is on harmaceutical nanotechnology, physical pharmacy and regulatory issues. He has published more than 200 research papers, one monograph, co-authored one book and edited three books. He has been awarded in pharmaceutical congresses and has led to awards of international and national patents. His research work has more than 3.000 cross references (h index 29).

Nunzio Denora is Associate Professor and research scientist in Pharmaceutical Technology at University of Bari, UNIBA, Department of Pharmacy - Drug Sciences. Since 2016, he is heading the Inter-University Consortium CIRCSMB research group of Bari (> 30 scientists) with the aim to develop "Inorganic-based Nano Drug Delivery Systems". His main interests include drug delivery and targeting, nanomedicine, multifunctional pharmaceutical nanocarriers. He has a productive track record of extensive multidisciplinary collaborations, yielding over 100 publications in high profile journals.

Dr. Harish Dureja studied Master in Pharmacy in Pharmaceutics from Punjabi University, Patiala. He earned Ph. D. in Pharmaceutical Sciences from Maharshi Dayanand University, Rohtak. He is presently working as a Professor in Pharmaceutics and IQAC Officer, Dept. of Pharmaceutical Sciences, M. D. University, Rohtak. He is also holding the position of Director IPR Cell and Director, Professional Consultancy Services at M.D. University, Rohtak. Dr. Dureja has numerous honors, awards and international publications to his credit.

Robert A. Freitas Jr. is Senior Research Fellow at the Institute for Molecular Manufacturing (IMM) in California, after serving as a Research Scientist at Zyvex Corp. in Texas during 2000-2004. He is the author of Nanomedicine (Landes Bioscience, (Vol. I) 1999, (Vol. IIA) 2003), the first technical book series on medical nanorobotics, and 2 other technical books, 54 peer-reviewed papers or book chapters, and 9 issued U.S. patents. He was awarded the Feynman Prize in Nanotechnology in 2009.

Dr. Haseeb A. Khan is a Distinguished Professor at the Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia. He is the Group Leader of Analytical and Molecular Bioscience Research Group and Chair Professor at Prince Sultan Research Chair for Environment and Wildlife. He is also a Member of Bio-nanotechnology Research Group as well as Member of Research Chair for Biomedical Applications of Nanomaterials. He was graduated from Aligarh Muslim University and received scientific training at USA, UK, France, Denmark and Finland. He is a Fellow of the Royal College of Pathologists (UK) and the Royal Society of Chemistry (UK). He has published around 300 articles, authored 2 books and 20 book chapters. He has also developed 8 software tools for biomedical applications, which have been published in reputed journals and demanded by more than 400 scientists from 40 countries. He is a recipient of Microsoft eScience Award.

Dr. Rehan Khan is working as a Scientist at Institute of Nano Science and Technology, Mohali, India. Currently his area of research is Drug delivery. His main research interest is to develop novel drug delivery system for targeted cancer therapy as well as arthritis and colitis. During his postdoctoral training, by using yeast/drosophila datasets, he was working on to develop synthetic lethal interactors of homologous recombination repair (HRR)-deficient cancer cells for selective killing of cancer cells while sparing normal cells.

Dr. Tae-il Kim is associate professor at Department of Biosystems & Biomaterials Science and Engineering, Seoul National University (Republic of Korea). He obtained his Ph.D. in Department of Chemistry in 2006 from Seoul National University. He was a post doctor in Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, prior to joining Seoul National University in 2010. His research is focused on the development of drug/gene delivery systems, nanomedicine, and biopolymers for biomedical applications.

Prof. Jianhua Liu obtained his PhD in inorganic chemistry from Chemistry College of Jilin University. He worked as a visiting scholar in Ulm University in Germany (2019). He currently works as Chief physician and Professor, Vice Director, Department of Radiology, the Second Hospital of Jilin University, China. Prof. Liu has authored more than 60 scientific papers in the medicinal chemistry field (H=27), including ACS Nano, Biomaterials, Small, Theranostics, ACS Appl Mater Interfaces, Nanoscale, Curr Top Med Chem, Curr Med Imaging Rev etc. He served as guest associated editor for journal of “Frontiers in Chemistry”. His research mainly focused on Synthesis of nanoparticles for medical imaging and therapy.

Kai Liu gained PhD degree in bioengineering and biomaterials at the University of Groningen in Netherlands. Then, he pursued postdoctoral research at the University of Groningen in Netherlands and Harvard University in US. Now, he has been working as a principle investigator and a full professor at Changchun Institute of Applied Chemistry of Chinese Academy of Sciences and heading a laboratory with research on functional biomaterials. He has published more than 50 papers and several book chapters on DNA, protein and hybrid biomaterials for application in bioelectronics and biomedicine.

Gang Liu received his MD degree from North Sichuan Medical College (China) in 2002 and PhD degree from Sichuan University (China) in 2009. Subsequently, He focused his training on nanomedicine and molecularimaging at the National Institutes of Biomedical Imaging and Bioengineering, National Institutes of Health. In 2012, he joined the Center for Molecular Imaging and Translational Medicine, Xiamen University. Currently he is a Full Professor of Biomedical and Bioengineering and his research interests include biomaterials, theranostics, and molecular imaging.

Mechanical Engineering at the Chang Gung University of Taiwan. He received the Bachelor degree from Mechanical Engineering of National Taiwan University in 1986, and earned his Master and Ph.D. degrees from Cornell University and the University of Wisconsin at Madison in 1989 and 1992 respectively. Dr. Liu had been working as a Post-doctoral research fellow at McMaster University of Canada, and also been as a visiting professor to the Tokyo Institute of Technology in Japan and Aachen University of Applied Science in Germany. Dr. Liu has been involved in pioneering work on the concepts of various polymer processing techniques. His research work deals with theoretical and experimental processing of various polymeric materials including biodegradable polymers. the processing of bioabsorbable materials for drug delivery, implants and tissue engineering. Dr. Liu received the Morand Lambla Award from the International Polymer Processing Society in 2008. He is the author of more than 300 scientific publications including 170 referred journal papers, editor and co-editor of 6 books and the author of 15 patents.

Dr. Uttam Kumar Mandal is as an Associate Professor at Department of Pharmaceutical Sciences & Technology, Maharaja Ranjit Singh Punjab Technical University (MRSPTU), Punjab, India. He has 9 years of teaching experience (out of which 5 years in IIUM, Malaysia), 10 years of research experience (out of which two years as Post-doctoral Fellow at University of Geneva, Switzerland). His research interest includes drug delivery, development of transdermal nanoformulations (transfersomes, ethosomes, niosomes), solubility enhancement, modern analytical techniques, bioavailability & bioequivalence. Based on his diverse fields of research experiences, he has published more than sixty research papers in various high impact factor journals.

Dr. Heidi M. Mansour is a faculty member in the College of Pharmacy, College of Medicine, and the BIO5 Research Institute at The University of Arizona (UA) in Tucson, Arizona (USA) with faculty member affiliations in the UA Institute of the Environment, and the UA NCI Comprehensive Cancer Center. Her research program has enjoyed funding from federal sources and the pharmaceutical industry. In addition to lecturing in the Graduate Ph.D. and Pharm.D. programs, Dr. Mansour leads her research lab where she trains postdoctoral scholars, visiting scholars, visiting professors, graduate students, Pharm.D. student researchers, and physician-scientist (MD/PhD) fellows.

Expert in Nano-biotechnology, Encapsulation & Targeting of Bioactive agents with substantial number of publications, 7 Patents, 5 Books & several Book-chapters. Author of the first book on Nanoliposomes; completed many industrial research projects, developed methods (e.g. “Mozafari Method”) for large-scale manufacture of controlled-release systems without using toxic agents. Recently introduced a novel technology for the encapsulation and delivery of bioactive material called "Tocosome".

Dr. Emanuele Papini graduated in Biology in 1983, and was post-graduate fellow at the University of Verona (Italy) between 1983 and 1985 working with Prof. P. Bellavite and Prof. F. Rossi on NADPH-oxidase activation mechanism. He obtained his Ph.D. in 1990 at the University of Padova in the laboratory of Prof. C. Montecucco, working on the intoxication mechanism of diphtheria toxin in collaboration with Dr. R. Rappuoli. In 1991 he became researcher at the Department of Biomedical Sciences, University of Padova. 1993-1994: Fellow scientist, Laboratory for Molecular Cell Biology, UCL, UK, working on intracellular trafficking of bacterial toxins with Prof. D. Cutler and Prof. C. Hopkins. In 1998 he became Professor of General Pathology, University of Bari. In 2001 he became PI, Department of Biomedical Science, University of Padova. His teaching activities: General Pathology, Immunology, Immunological Biotechnology, Nanobiotechnology. His main research projects are in the field of bacterial toxins and adhesins action mechanisms, nanoparticles and peptides in medicine and pathology. He is author in about 92 scientific publications and inventor in two patents.

Dr. Mahfoozur Rahman is an Assistant Professor at the Department of Pharmaceutical Sciences, Faculty of Health Science, Sam Higginbottom University of Agriculture, Technology & Sciences (SHUATS), Allahabad, India. His major areas of research include development and characterization of nanosized drug delivery systems for inflammatory disorders including psoriasis, arthritis, neurodegenerative disorders and cancer, etc. To date he has published over 90 publications in peer reviewed journals, 17 book chapters, 04 International books, three articles in international magazines.

Dr Sahoo obtained a doctorate (Ph.D.) in chemistry from the University of Delhi, Delhi, India. Presently, Dr Sahoo is a scientist at the Institute of Life Sciences, Bhubaneswar, India. He has nearly 20 years of experience in the research related to nanotechnology based drug delivery to cancer. Dr Sahoo has authored more than 80 manuscripts, 5 patents and edited one book “Nanotechnology in Health Care”

Dr. Rajesh Kumar Singh received his B. Pharmacy (2003) and M. Pharmacy (2005) from UIPS, Panjab University, Chandigarh. He started to teach Pharmaceutical Chemistry at the Shivalik College of Pharmacy, Nangal, where he completed his PhD in 2013 from IKG Punjab Technical University, Jalandhar. He has guided 17 M. Pharmacy students and currently guiding 03 PhDs. He has to his credit more than 50 research papers of JCR IF from 1-4.8. He has 60 National and International Conference Abstracts, 2 Books and 6 Best Paper Awards and 05 projects from different government agencies. He is currently an EBM of 06 International Journals, reviewed more than 100 International papers, and availed 1 Travel grant to attend the International Conference.

Vladimir P. Torchilin, Ph.D., D.Sc. is a University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. His interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy. He has published more than 400 original papers, more than 150 reviews and book chapters, wrote and edited 12 books, and holds more than 40 patents. Google Scholar shows more than 44,000 citations of his papers with H-index of 96. He is Editor-in-Chief of Current Drug Discovery Technologies, Drug Delivery, and OpenNano, Co-Editor of Current Pharmaceutical Biotechnology and on the Editorial Boards of many other journals. He received more than $30 M from the governmental and industrial sources in research funding. He has multiple honors and awards and in 2011, Times Higher Education ranked him number 2 among top world scientists in pharmacology for the period of 2000-2010.

Dr. Thao T.D. Tran received his PhD degree in Pharmacy at Kangwon National University, South Korea. His research interests are design and engineering of drug delivery systems for enhancing drug bioavailability, including fabrication and functionalization of nanoparticles for improving therapeutics efficacy, particularly in cancer therapeutics and diagnostics. He is currently serving as an editorial board member and a scientific reviewer for several journals.

Francesca Ungaro is Associate Professor of Pharmaceutical Technology at the Department of Pharmacy, School of Medicine of University of Napoli Federico II, Italy. She received her Degree in Pharmacy in 1999 and a Ph.D. in Pharmaceutical Sciences in 2003. Prof Ungaro’s research activity has been focused on the design and development of innovative drug delivery systems, with a special focus on nano- and micro-particulate carriers. She coordinated and participated to several research projects funded by local institutions, Italian Ministry of research and research foundations. Results are documented by 72 peer-reviewed articles, 1 European patent, 4 book chapters, more than 100 presentations at symposia and 20 oral communications.

Dr. Wu is currently an Assistant Professor in Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas M.D. Anderson Cancer Center. Dr. Wu obtained her PhD degree at the University of Queensland. She has expertise in target discovery, in vitro and in vivo cancer models, nanotechnology, and molecular biology techniques for studying mechanisms of action and resistance. Her research focuses on: 1) Developing strategies to overcome immune suppression in cancer; 2) Developing novel strategies to enhance patient survival in ovarian cancer; 3) Developing novel nanoparticle platforms for tumor-targeted delivery; and 4) Early detection of ovarian cancer.

Dr. Xinghua Xia received the BS (1986) and MS degree (1989) in chemistry from Xiamen University, China. He received the Ph.D. degree in electrocatalysis in 1996 from the University of Bonn, Germany. During the following five years, he worked at the Universität der Bundeswehr, München, at the Fritz-Haber-Institute of the Max-Planck-Society in Berlin, Germany and the Debye Institute of the University of Utrecht, The Netherlands, performing postdoctoral studies on surface electrochemistry, electrochemical nanostructuring, and semiconductor electrochemistry. Since 2001, he became a Professor at the Department of Chemistry, Nanjing University, China. The current research activities of his group are focused on the understanding of interfacial of biomolecules and cells on substrates, micro/nanofluidics, nanobiosensors, plasmonic biosensors.

Dr. Hamed Barabadi has been a PhD scholar in the Department of Pharmaceutical Biotechnology at Shahid Beheshti University of Medical Sciences, Tehran, Iran, since 2016. He graduated as a Doctor of Pharmacy (PharmD) from Mazandaran University of Medical Sciences, Sari, Iran, in 2014. Prior to starting his PhD, he served as a pharmaceutical expert at the Food and Drug Administration at the Department of Inspection and Supervision in Golestan Province, Iran, for two years.

Dr. Keyur D. Bhatt obtained his Ph.D. degree (2013) from Department of Chemistry, Gujarat University, India. Since June 2017, Dr. Bhatt is Head of the Department of Chemistry at Mehsana Urban Institute of Science, Ganpat University, India. His areas of interest and specialization involve the Design, Synthesis, Characterization of Supramolecule, Fluorescence sensors and Nanoaprarticles. Also, to study their Ion-binding properties with biological and environmentally important, metal ion, Amino acids, DNA, etc. Furthermore, Synthesis and characterization of organic molecules, Applications in the field of Metal complexes, Sensor and Nanomaterials, etc. Dr. Bhatt has 2 Indian patents, 30 Research articles and 9 books in International Journals to his credit.

Dr. Swati Gupta is an author and Professor of Pharmaceutics at Amity Institute of Pharmacy,Amity University, Noida, India. Dr. Gupta has nearly seventeen years of research/teaching experience. She has supervised 17 M.Pharm and 2 Ph.D. students. Dr. Gupta has over fifty publications to her credit published in international journals of high scientific impact and has contributed several chapters in many outstanding reference books. Dr. Gupta has presented several research papers in international/national conferences and also serves as the reviewer of several international journals.Her research interests include drug delivery using nanocarriers, drug targeting, molecular pharmaceutics, and nanotoxicity.

Dr. Md. Torequl Islam obtained PhD in Biotechnology in Natural Products. He is presently serving as faculty Member, Pharmaceutical Sciences at Novel Global Community Educational Foundation, Australia and Lecturer at Department of Pharmacy in BSMRSTU, Gopalganj, Bangladesh. He has been recognized with honors and awards such as World Championship 2018 in Biotechnology, Federal University Postgraduate Research Scholarship, Brazilian Journal of Biodiversity and Biotechnology 2016, Brazil and Isaac Newton Research Award 2016 in Genetics & Lifetime Membership at Photon Foundations.

Dr. Pradeep K. Jha is a Scientist at Indian Institute of Technology Delhi, prior to that he has been working as a Senior Research Scientist at the School of Medical Science and Technology; and Science and Technology Entrepreneurship Park at IIT Kharagpur, India for a decade. He is a founder director of Institute of Biomedical Innovation and Entrepreneurship, Kharagpur, and serving as a consultant and co-Investigator of several biotech startups for small business incubation. He has developed innovative quality tools and techniques for pharmaceutical quality management. He is a member of professional societies like ISSRF, SAI, WABT France, and EUROMA; and referee of several journals.

Currently, I am working at USFDA/CDER/OGD as an ORISE fellow on different projects including immediate and controlled release dosage forms. I completed my Ph.D. in Pharmaceutics at University of Connecticut in May 2018 and since then have been working with USFDA. My research focus is on formulation design and evaluation of oral dosage forms (crystalline and amorphous nanoparticles) for BCS class II and II/IV drugs in order to improve their oral bioavailability, development of liposomal drug products and spray/freeze dried drug products. I have 7 research awards, 11 research publications, 2 book chapters, 26 poster presentations and 3 oral presentations. I have industry experience of ~2.5 years in formulation development.

Currently, Dr. Zeeshan is working as an Assistant Professor at Umm Al Qura University. His research in Ph.D. broadly fell in the area of Organic, Pharmaceutical and Analytical Chemistry. Particularly he specialized in developing new methods and protocols for in vitro analysis of drug interactions. He also researched as a Visiting Scholar at the Department of Agricultural and Biological Engineering, Purdue University, Indiana and his mentor was Prof. Joseph Irudayaraj, a renowned scientist in the field of nanotechnology. At Purdue, Zeeshan focus was on the development of nanoparticles for biosensing and targeted drug delivery for cancer therapeutics. He developed folic acid and doxorubicin tagged nanoparticles through a novel chemical linking protocol. At Umm Al Qura University, He completed the project related with the Drug Design of Isoxazolidine Nucleosides and Nucleosidyl Podophyllotoxin derivatives and now involved in the proposal with Drug Design of bi-functional hybrid agents with combined anti-hyperglycemic and anticancer activities financed by the Kingdom’s central funding body. He has published 47 peer-reviewed research papers in national and international journals.

Dr Md Nafiujjaman is currently working as a Research Associate at Biomedical Engineering, Institute for Quantitative Health Science and Engineering, Michigan State University. He received M.Eng and PhD from the Korea National University of Transportation in Chemical Biological Engineering and Green Bioengineering, respectively. Before this, he completed a B.S. in Pharmacy at the University of Development Alternative, Dhaka, Bangladesh. His research interest focuses on synthesis, characterization and biological application of nanomaterials including organic, inorganic and polymeric hybrid nanomaterials for imaging-guided cancer therapy. His research objective includes developing biocompatible and biomimetic tools for theranostic using magnetic particle imaging and photoacoustic imaging.

Dr. Ayca Bal Ozturk received her bachelor’s, master’s and PhD degree in Chemical Engineering from Istanbul University, Turkey. In her PhD thesis work she centered on developing the targeted polymeric nanoparticles for the cancer therapy. In 2016, she joined the lab of Prof. Ali Khademhosseini at Harvard Medical School, Harvard-MIT’s Division of Health Sciences and Technology as postdoctoral scientist for one year and then joined Faculty of Pharmacy as assistant professor of Analytical Chemistry Department in Istinye University. Her research interests include mainly nanostructured smart biomaterials, design and synthesis of innovative micro/nanoscale biomaterials as well as regulating stem-cell differentiation with the conclusive purpose of generating tissue-engineered organs, designing the next generation nanoparticles for efficient targeted drug delivery.

Dr. Sanjay B. Patil obtained his Ph. D. degree in Pharmaceutical Sciences from The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India in 2010. Presently he is working as Associate Professor at SNJB’s Shriman Sureshdada Jain College of Pharmacy, Chandwad, Nashik, India. His area of research comprises novel drug delivery systems including in situ gelling system, microparticles, and gastroretentive drug delivery systems. He has published and presented several papers in national and international journals and conferences. He is an editorial board member and reviewer for various journals.

Dr. Fabíola Praça is a Ph.D. Associate researcher at School of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo USP, Brazil, with master´s degree in Pharmaceutical Sciences (2004) and Doctorate Degree in Pharmaceutical Sciences by the University of São Paulo – FCFRP-USP (2010) and postdoctoral fellow at the Research Institute for Medicines and Pharmaceutical Sciences Nanomedicine and Drug Delivery Systems (IMED) at the Faculty of Pharmacy of the University of Lisbon, Portugal (2011). Dr. Praça has experience with pharmaceutical technology, particularly to the development, characterization, and efficacy of nanocarriers with different physicochemical properties used for topical or transdermal drug delivery systems.

Dr Abbas Rahdar has received his PhD in nanoscience and nanotechnology from nanoscience and nanotechnology research institute of Kashan, Iran, and has completed his Masters Degree in physics from University of Sistan and Baluchistan , Zahedan, Iran. His major areas of research interest include nano particles synthesis and physical characterization, adsorption of nano-materials , cytotoxity of nano- materials, micro-emulsion, ionic liquids ,water nano-droplets and oil nano-droplets containing hydrophilic and hydrophobic bio-compound,and drug delivery. Till date he has authored more than 60 publications in various peer-reviewed journals, 2 books on nanoscience and nanotechnology.

Degree in Pharmacy from the Methodist University of Piracicaba - Unimep (2005). Master and PhD from the School of Chemical Engineering, State University of Campinas - Unicamp (2005 and 2012). In the master made sandwich program at the Faculty of Pharmacy of the Federal University of Rio Grande do Sul - UFRGS (2007-2008), and held a doctorate sandwich program at the Faculty of Pharmacy, University Fernando Pessoa - UFP in Porto, Portugal (2010-2011 ). She is currently professor Program in Industrial Biotechnology and pharmacy institute at University Tiradentes and researcher at the Institute of Technology and Research.

Dr. Ankur Vaidya did his PhD from Deptt. of Pharmaceutical Sciences, Dr. H. S. Gour University, Sagar (M.P.) India in year 2013. Dr. Vaidya has a teaching and research experience of more than 8 years and is currently working as Asst. Professor in Pharmacy College UPUMS, Saifai, Etawah (U.P.) India. Dr. Ankur has a key research interest in NDDS and colon specific drug delivery systems and published around 25 outstanding publications in various International journals with h-index of 10 and i-10 index of 10. Dr Vaidya has credited as reviewer of various international journals and published 4 international book chapters and 1 national book. Dr. Ankur has guided 16 postgraduate.

Dr. Yadav is competed his B.Pharm, M. Pharm. and Ph.D (Pharmaceutical sciences) from Department of Pharmaceutical Sciences, Dr. H. S. Gour Central University, Sagar (M.P.) India. He has authored over 39 research & review articles in various International and National Journals and he author one book chapters in reference books. He is a recipient of “Best Cited Paper Award” by International Journal of Pharmaceutics (Elsevier). Recently, Dr Yadav received “Outstanding Teacher Award in Pharmaceutics” by APTI-MP State Branch Bhopal (MP) India.). Dr. Yadav is a principal investigator of various research project approved by various Indian research agencies. He is review editor of Frontier in Pharmacology (Impact Factor 4.4). He is a member of editorial board of many journals like Asian Journal of Biomaterial Research, Asian Journal of Pharmacy and Pharmacology etc. He is vice president of MP state branch Society of Pharmaceutical Education and Research (SPER). Currently Dr. Yadav is serving as a Principal and Professor in Bhagyoday Tirth Pharmacy College, Khurai Road, Sagar (MP).

Dr. Ali Zarrabi is an Associate Professor at the Departments of Biotechnology of the University of Isfahan. His current research interests include Nano biotechnology, Nano medicine, Drug Delivery Systems, Nanotheranostics, Nanomaterial, SPIONs and Surface Modifications. Dr. Zarrabi has been a member of American Chemical Society (ACS), British Society for Nano medicine, European Society for Nano medicine, American Association for the Advancement of Science (AAAS) and Nanotechnology Strategic Committee of University of Isfahan. He received his B.S. of Chemical Engineering from Isfahan University of Technology, Iran, in 2004, and the M.S. and Ph.D. degrees from Sharif University of Technology, Tehran, in Chemical Engineering (2007) and Nano biotechnology (2011), respectively.